Search

Meet the Luo (Weibo) Lab team.

Luo (Weibo) Lab news.

Meet the Shaul / Mineo Lab team.

Zhijian “James” Chen Elected to the Fellowship of the Royal Society.

Skip to main content HCC Risk Stratification and Precision Screening Although patients with cirrhosis are at high risk of HCC, there is variation in risk among individuals. We are collaborating with Dr. Hoshida at UT Southwestern to validate a novel blood-based signatures to help identify patients at…

Skip to main content Net Benefit of HCC screening We have promoted the concept of net benefit for HCC screening, which involves balancing early detection with potential screening-related harms. We have characterized the clinical benefits of screening, including improved early tumor detection and asso…

Skip to main content Effectiveness of HCC Treatments Treatment strategies for HCC are evolving rapidly, with immunotherapy combinations showing promising results in large phase 3 clinical trials. However, effectiveness in clinical practice can differ from efficacy in trials given differences in patie…

Skip to main content Lab Gallery Ahmed presenting research at BHI in September 2024. Krishna presenting to Dr. Jamieson at Department Retreat in October 2024. Group at Department retreat in October 2024 Lab celebrating Thanksgiving 2024 at Main Event Entertainment Center! Lab dinner November 2024 Lab…

Shaul / Mineo Lab news.

Learn about the Shaul / Mineo Lab's research.